The Global 3D Printed Drugs Industry is expected to reach US$ 742.88 Million by 2032, with a CAGR of 9.2% between 2022 and 2032. According to FMI, the market is expected to produce US$ 307.54 million by the end of 2022. The growing demand for 3D-printed medications is largely driven by their large-scale uses in …